The mRNA vaccines have long been funded and researched before Trump was ever elected, and are partially owned by the government, according to official documents.

By Jacob M. Thompson - January 13, 2023

On May 15th, 2020, President Donald Trump and his administration launched Operation Warp Speed (OWS), a move that directed a slew of federal government divisions to devote time, money, and resources – in a public-private partnership – to rapidly develop “safe and effective” vaccines to prevent the transmission of Covid-19, along with distributing and administering them.

In a joint explanation by the Department of Health and Human Services (HHS) and the Department of Defense (DoD), the two federal departments further detailed the purpose of OWS:

Operation Warp Speed (OWS) aims to begin delivery of 300 million doses of a safe, effective vaccine for COVID-19 by January 2021, as part of a broader strategy to accelerate the development, manufacturing, and distribution of COVID-19 vaccines, therapeutics, and diagnostics (collectively known as countermeasures).

OWS will allow countermeasures such as a vaccine to be delivered to patients more rapidly while adhering to standards for safety and efficacy.

Rather than eliminating steps from traditional development timelines, steps will proceed simultaneously, such as starting manufacturing of vaccines and therapeutics at industrial scale well before the demonstration of efficacy and safety as happens normally. This increases the financial risk, but not the product risk.

And even though OWS was announced on May 15th, the government admits that they were already working with some pharmaceutical companies to develop a vaccine – including a $483 million grant to Moderna on April 16th, and $456 million in funds for Johnson & Johnson’s (Janssen) on March 30th.

However, it appears the Trump administration was already working with the pharmaceutical giant Moderna to create a mRNA vaccine before OWS was launched, and even before a single case of Covid-19 was reportedly confirmed in the United States . . .

[SNIP]